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Complexes of copper (II) with hesperetin, naringenin, and apigenin of general composition [CuL2(H2O)2] · nH2O( 1–3)h a v e
been synthesized and characterized by elemental analysis, UV-Vis, FT-IR, ESI-MS, and TG-DTG thermal analysis. The free ligands
and the metal complexes have been tested in vitro against human cancer cell lines hepatocellular carcinoma (HepG-2), gastric
carcinomas (SGC-7901), and cervical carcinoma (HeLa). Complexes 1 and 3 were found to exhibit growth inhibition of SGC-7901
and HepG2 cell lines with respect to the free ligands; the inhibitory rate of complex 1 is 43.2% and 43.8%, while complex 3 is
46% and 36%, respectively. The interactions of complex 1 and its ligand Hsp with calf thymus DNA were investigated by UV-Vis,
ﬂuorescence, and CD spectra. Both complex 1 and Hsp were found to bind DNA in intercalation modes, and the binding aﬃnity
of complex 1 was stronger than that of free ligand.
Copyright © 2009 Mingxiong Tan et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The success of cisplatin and its derivatives as anticancer
agents has stimulated the development of metal-based
compounds[1–4].Recently,interestspossessed incopper(II)
complexes are increasing due to their possible medical uses
as antitumor agents. And, new bioactive ligands, involving
natural product ligands [5–7], have been applied for the
design of Cu-coordination novel drugs; for that, naturally
occurring compounds haveserved asa majorsourceof drugs
for centuries [8–10].
Flavonoids are phenolic compounds widely distributed
in plants, which display a variety of biological activities,
such as antioxidant, anti-inﬂammatory, blood lipid-lowing,
and anticarcinogenic activities [11–13]. Many ﬂavonoids
are natural chelators and, ﬂavonoid metal complexes have
showed signiﬁcantly higher cytotoxic activity than those of
the parent ﬂavonoids, such as quercetin, morin, and chrysin
and so forth [14–16]. Besides, it is demonstrated that the
coordination of copper(II) ion with bioactive ligands can
actually improve the pharmaceutical activity of the drugs
themselves and reduce their toxicity eﬀects [17–19].
Hesperetin (5,7,3  -trihydroxy-4 -methoxy-ﬂavanone,
Hsp, Scheme 1), naringenin (4 ,5,7-trihydroxyﬂavanone,
Nrg, Scheme 1) and Apigenin (4 ,5,7-trihydroxyﬂavone,
Apg, Scheme 1), are biologically active ﬂavonoids,
commonly found in fruits and vegetables [20]. They
have been reported to exhibit antitumor eﬀects against
breast cancer and hepatoma HepG2 cell lines [21, 22].
In addition, some metal complexes of Hsp and Nrg have
been found to exhibit antioxidant and anticancer activities
[23, 24]. Nrg schiﬀ-base La(III) complex against the A-549
cell line was more potent than cisplatin at most experimental
concentrations [25, 26]. Also, Cu(II) complex of Nrg schiﬀ-
base possessed potent antioxidant activity and better than
standard antioxidants like vitamin C and mannitol [27].2 Bioinorganic Chemistry and Applications
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Scheme 1: Structures of the ligands.
T h ea i mo ft h i ss t u d yi st op r e p a r en e wc o p p e r ( I I ) -
based antitumor compounds and investigate the synergistic
eﬀects upon ﬂavonoids coordination with Cu(II) ion. In
this paper, three copper(II) complexes with Hsp, Nrg, and
Apg have been synthesized and characterized by elemental
analysis, UV-Vis, FT-IR, ESI-MS, and TG-DTG thermal
analysis, and their cytotoxic activities were estimated against
HepG-2, SGC-7901, and HeLa cell lines in vitro. The binding
properties with calf thymus DNA of Hsp and its Cu(II)
complex, which have good activities against the tested cell
lines, were investigated through UV-Vis, ﬂuorescence, and
circular dichroism (CD) spectroscopy.
2. Experimental
2.1. Instrumentation and Materials. Hesperetin, naringenin,
and apigenin were purchased from Shaanxi Huike Botanical
Development Co., Ltd., and the products (compounds
purity > 98%) were identiﬁed by spectral methods. The
solvents and metallic salts used were analytical grade.
All the materials were used as received without fur-
ther puriﬁcation unless noted speciﬁcally. Tris-HCl-NaCl
buﬀer solution (5mM Tris, 50mM NaCl, pH was digi-
tal adjusted to 7.35 by titration with hydrochloric acid
using a sartorius professional meter professional meter,
tris(hydroxymethyl)aminomethane) (Tris) was prepared
usingdoubledistilledwater.CalfthymusDNA(ct-DNA)was
purchased from Sino-American Biotech. Co. Ltd, Beijing. A
Tris-buﬀersolutionofct-DNAgavearatioofUVabsorbance
at 260nm and 280nm of ca. 1.8 ∼ 1.9 : 1, indicating
that the DNA was suﬃc i e n t l yf r e eo fp r o t e i n .T h eD N A
concentration was determined spectrophotometrically from
the molar absorption coeﬃcient (6600M−1cm−1) at 260nm.
Stock solutions were stored at 4◦C and used no more than
4 days after preparation. Infrared spectra were obtained
on a Perkin-Elmer FTIR Spectrometer. Elemental analyse
was carried out on a Perkin Elmer 2400 Series II CHNS/O
elemental analyzer. TG-DTG thermal analyses of the com-
plexes were investigated on a thermogravimetry diﬀerential
thermal analysis apparatus (Pris Diamond, America). UV-
Vis absorption was performed on a Varian Cary100 UV-Vis
spectrophotometer. Fluorescence measurements were per-
formedonaShimadzuRF-530/PCspectroﬂuorophotometer.
The Circular Dichroic spectra of DNA were obtained by
using a JASCO J-810 automatic recording spectropolarime-
ter operating at 25◦C. The region between 220 and 320nm
was scanned for each sample.
2.2.SynthesisofComplexes. Synthesisof[Cu(Hsp)2(H2O)2]·
H2O( 1): An ethanol solution (10mL) of Hsp (0.0604g,
0.2mmol) was added to a aqueous solution (15mL) of
CuCl2 ·2H2O (0.0204g, 0.12mmol) and was adjusted pH to
7-8 with ammonia solution. The mixture was reﬂuxed with
stirring for 12 hours, and brown precipitate formed during
reﬂux and then allowed to cool to room temperature and
ﬁltered. The solid was washed with water and ethanol, and
then air-dried for 2 days. Calc. for [Cu(Hsp)2(H2O)2]·H2O,
C,53.37;H,4.48.Found:C,53.68;H,4.51%.IR(KBr):3423,
1614, 1564, 1375, 1166cm−1. ESI-MS: m/z 703.
Synthesis of [Cu(Nrg)2(H2O)2]·H2O( 2): this green
compound was synthesized by the same method as that
employed for 1. Calc. for [Cu(Nrg)2(H2O)2]·H2O, C, 54.59;
H, 4.28. Found: C, 54.75; H, 4.26%. IR (KBr): 3401, 1613,
1566, 1374, 1254 cm−1. ESI-MS: m/z 642.4.
Synthesis of [Cu (Apg)2(H2O)2]( 3): this yellow-green
compound was synthesized by the same method as that
employed for 1. Calc. for [Cu (Apg)2(H2O)2], C, 56.47 ; H,
3.48. Found: C, 56.81; H, 3.76%. IR (KBr): 3413, 1626, 1597,
1356, 1176cm−1. ESI-MS: m/z 638.
2.3. Cytotoxic Activity Assay In Vitro. Cell lines: human
cancer cell lines hepatocellular carcinoma (HepG-2), gastric
carcinomas (SGC-7901), and cervical carcinoma (HeLa)
were obtained from Shanghai Cell Bank in Chinese Academy
of Sciences. Cell lines (Gibco, Scotland, UK) were grown
in Dulbecco’s modiﬁed Eagles medium (DMEN) at 37◦Ci n
a humidiﬁed atmosphere of 5% CO2/95% air. Cytotoxicity
evaluation: assays of cytotoxicity were conducted in 96-well,
ﬂat-bottomed microtitre plates. The supplemented culture
medium with cell limes was added to the wells. Compounds
were dissolved in the culture medium with 1% DMSO to
various concentrations, and the solutions were subsequently
addedtoasetofwells.Controlwellscontainedsupplemented
media with 1% DMSO. The microtiter plates were incubated
at 37◦C in a humidiﬁed atmosphere of 5% CO2/95% air forBioinorganic Chemistry and Applications 3
a further 3 days. Assessment of cytotoxicity was carried out
by using a modiﬁed method of the Mosmann-based 3-(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) assay. At the end of each incubation period, MTT
solution (10μL, 5mg/mL) was added into each well, and
the cultures were incubated further for 4 hours at 37◦Ci n
a humidiﬁed atmosphere of 5% CO2/95% air. After removal
of the supernatant, DMSO (150μL) was added to dissolve
the formazan crystals. The absorbance was read by enzyme
labelling instrument with 570/630nm double wavelength
measurement.
2.4. DNA Binding. The UV-Vis absorption titrations, ﬂuo-
rescenceemissionspectra,andCDabsorptionspectrastudies
were performed at room temperature. Hsp and its Cu(II)
complex were all dissolved in a small amount of DMSO due
to their poor solubility, then diluted to a concentration of
2.0 ×10
−5 mol/L with Tris-HCl-NaCl buﬀer solution (5mM
Tris, 50mM NaCl, pH = 7.35). Absorption titrations were
performed by using a ﬁxed compound concentration (2.0 ×
10
−5 mol/L); ct-DNA stock solution (1.0 × 10
−4 mol/L) was
added 30μL each time and gradually increased up to a
suﬃcient concentration for studying. While measuring the
absorption spectra, the solutions were allowed to incubate
for 10 minutes before the absorption spectra were recorded,
and an equal amount of ct-DNA was added to both the com-
pound solution for the reference solution to eliminate the
absorbance of ct-DNA itself. Fluorescence Emission spectra
of compounds were performed by using a ﬁxed compound
concentration (2.0 × 10
−5 mol/L) and an increasing amount
of DNA (1.0 × 10
−4 mol/L). Samples were observed between
200 and 800nm. The CD absorption spectra of ct-DNA
(1.0×10
−4 mol/L)wererecordedintheabsenceandpresence
of compounds (2.0 × 10
−5 mol/L). The sample solutions
were mixed and allowed to equilibrate at room temperature
for 60 minutes before measurements. Each sample solution
was scanned in the range 200–400nm UV-Vis region with a
screening rate of 100nm/min at room temperature.
3. Results andDiscussion
3.1. Synthesis of the Complexes. The Cu(II) complexes were
synthesized by aqueous solution of CuCl2·2H2O and the
ethanol aqueous solution of Hsp, Nrg or Apg in 1 : 2
molar ratio (metal salt/ligands). Ligands were deprotonated
by adding ammonia solution. The structures of copper(II)
complexes were characterized by elemental analysis, UV-Vis,
FT-IR, UV–Vis, TG-DTG, and ESI-MS measurements.
The elemental analysis data of the copper(II) complexes
agreed with the theoretical values within the limit of experi-
mental error. The ESI-MS of complexes were investigated in
H2O-DMSO (1 : 1) solution, the characteristic peaks at m/z
703 and 642 corresponding to [M+H-H2O]+of complexes 1
and 2, and that of peak at m/z 638 assigning to [M +H]+ of
complex 3.
UV-Vis spectrum of free ligands and their Cu complexes
suggested that 4-keto and 5-hydroxy region of the ﬂavonoids
may be considered as the possible chelating sites. For
Table 1: FT-IR spectrum data (cm−1) for the free ligands Apg, Hsp,
Nrg, and their Cu(II) complexes.
Compound ν (C=O) ν (C=C) ν (C–OH) ν (O–H) ν (M–O)
Apg 1651 1608 1354 3291 —
Apg-Cu 1626 1597 1356 3413 607
Hsp 1636 1612 1360 3132 —
Hsp-Cu 1614 1564 1375 3423 598
Nrg 1629 1603 1388 3290 —
Nrg-Cu 1613 1566 1374 3401 595
Table 2: Thermal analytical data for complexes.
Compound Dehydration Decomposition
temperature (◦C) temperature (◦C)
T1 T2 Weight
loss (%)
T3 T4
Total
weight loss
(%)
Hsp-Cu 100 250 7.2 347 540 55.9
Nrg-Cu 94 117 7.9 248 440 76.5
Apg-Cu — 247 5.2 420 580 55.9
T1–T2: temperature range corresponding to complex dehydration; T3–T4:
temperature range corresponding to complex decomposition.
example, free Apg exhibits an UV-Vis absorption maximum
in DMSO solution at 206–250nm, corresponding to the A
ringportion,andaweekbandat268–316nm,corresponding
to the B ring portion. Upon binding with the Cu(II) ion,
formingcomplex 3,themaximumabsorptionbandisshifted
to 235–286nm and the weak band shifted to 290–340nm
with respect to the free ﬂavonoid, suggesting an interaction
of the Cu(II) ion with the condensed ring of the ﬂavanone
in positions 4 and 5. These results are in agreement with the
results of others, [28–31] which indicate that this band shift
is caused by the binding of the metal ion in this position.
FT-IR spectrum data in KBr of free ligands and their Cu
complexeswerecomparedinTable 1.Theabsorptionaround
3200cm−1 due to phenolic hydroxyl in the free ligands
shows signiﬁcantly spectral change in all the Cu complexes,
indicating the chelate formation through hydroxyl group.
The Cu complexes show a medium broad band around
3400cm−1 indicating coordinated water, later conﬁrmed by
TG-DTGthermalanalysis.Theintenseabsorptionbandsdue
to ν(C=O)offreeligandsat1630–1650 cm−1 hasalsoshifted
to lower frequencies at 1623–1626cm−1in the Cu complexes.
Thus it suggests that ﬂavonoids are coordinated with Cu(II)
through oxygen atoms of –OH and C=Og r o u p s[ 31]. This
contention is further conﬁrmed by the presence of ν (M–O)
bands at about 600cm−1 in the far IR frequency region.
The TG-DTG curves and thermal data for the dehy-
dration and decomposition of the complexes are given in
Table 1 and Figure 1. The results showed that the thermal
decomposition of complex 1 displayed three stages from
30◦C to 600◦C. The ﬁrst stage of decomposition from 30◦C
to 100◦C was connected with the dehydration processes. The
mass loss value of 2.09% was involved in the loss for two
water molecules in the outer coordination sphere, which4 Bioinorganic Chemistry and Applications
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Figure 1: TG-DTG curves of the Cu(II) complexes.
was in close agreement with the calculated mass loss value
of 2.6%. The next dehydration processes appeared in the
temperature ranges from 250◦C to 300◦C. In fact, it was
very diﬃcult to distinguish between the dehydration steps
for inner and outer spheres from the graphic data. However,
the total observed mass loss value of 5.2% was in close
agreement with the calculated mass loss value of 5.13% for
the two coordinated water molecules. The last mass loss
stages were considered as the case of the decomposition
of the ring breaking of the ligand and the formation of
metal oxide. Complex 2 exhibits a sharp weight loss at
temperature of about 253◦C–440◦C, which corresponds to
thedegradation of theligand moleculesandthe formationof
metal oxides. The dehydration process occurs at temperature
rangeof30◦C–94◦Cand124◦C–253◦C,corresponding tothe
outer sphere and coordinated water molecules. The thermal
decomposition process of complex 3 is basically the same as
that of complex 1. The dehydration process occurs in only
one mass-loss step up to 247◦C with 5.2%, which is in close
agreement with the calculated mass loss value of 5.5% for the
two coordinated water molecules in inner spheres.
Basedontheseresults,thepossiblestructuresofthecom-
plexes were suggested. As shown in Scheme 2, the copper(II)
complexeshavethegeneralformula[Cu(L)2(H2O)2]·nH2O,
where L is the ligands, and n = 0f o rA p g ,a n dn = 1 for Hsp
or Nrg. The complexes are air stable for extended periods
and soluble in DMF, dimethyl sulphoxide (DMSO), slightly
solubleinMe2CO,andCH3OH,butscarcelysolubleinwater.
3.2. Cytotoxic Activity Assay In Vitro. Cytotoxicities in vitro
of Hsp, Nrg, and Apg and their copper(II) complexes have
b e e ne s t i m a t e db yM T Ta s s a y[ 32] against three typical
human tumour cell lines involving HepG-2, SGC-7901 and
HeLa. As shown in Figure 2, it is remarkable that complexes
1 and 3 exhibited cytotoxicity higher than that of complex 2
against the selected cell lines. Against the SGC-7901 tumour
cell line, the activity of complex 1 is 43.2%, while 3 is
46%, ﬁfteen times stronger than that of Apg, and against
HepG2,theactivityofcomplex1is43.8%,whilecomplex3is
36%, ten times stronger than that of Apg. However, complex
2 showed relatively signiﬁcant inhibitory rate only against
HepG2 cell line than that of Nrg.
Nrg and Apg are structurally similar with the same A
and B rings, and Apg is a planar molecule in its rings A
and C. The ligand Apg was found to show lower activities
against the tested cell lines than the analogous ligand Nrg.
However,theCu(II)complexofApgexhibitedhigheractivity
than the Cu(II) complex of Nrg, presumably the ﬂavone
planar structure of Apg is important for retaining its original
planarity in the Cu(II) complex and plays an important role
in the enhanced antitumour activity of the complex [33].
It is noteworthy that, Hsp and Nrg share similar structures
but have diﬀerent hydroxyl (OH) substitutions in ring B. In
contrast to the inhibitory activity of the Cu(II) complexes of
Nrg and Hsp, the high activity of Cu(II) complex with Hsp
may be related to the diﬀerent hydroxyl (OH) substitutions
in ring C and the synergistic action of copper(II) ion with
ligands [34–36].
3.3. DNA Binding Studies of 1 and Hsp. DNA is the
primary pharmacological target of many antitumor com-
pounds. Conformational changes of DNA directly aﬀect
genetic expression, which is closely related to carcinogen-
esis and anticarcinogenesis. Similarly, interactions between
small molecules and DNA rank among the primary action
mechanisms of antitumour activity. DNA replication in
tumour cells will be blocked by the intercalation of smallBioinorganic Chemistry and Applications 5
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molecule between the base pairs of DNA [37, 38]. Generally,
active compounds are required to possess approximately
planar structure, with a medium-sized planar area and
some hydrophobic character. In order to investigate the
binding properties with DNA of Hsp and its copper(II)
complexes, which have signiﬁcant eﬀect against the tested
cell lines, a series of spectroscopic studies including UV-Vis,
ﬂuorescence, and CD spectra were carried out.
It is well documented that complexes copper(II) are
capable of interaction with nucleic acids [39–41], and
intercalative π ± π stacking of the aromatic rings of the
metal complexes with the DNA bases aﬀects the transition
dipoles of the molecules and usually leads to a reduction in
its absorbance [42]. The absorption titrations were carried
out to determine the DNA binding of Hsp and its copper(II)
complex in tris(hydroxymethyl)aminomethane (Tris) buﬀer.
The UV-Vis absorption spectra of Hsp and complex 1 in
the absence and presence of calf thymus DNA are shown in
Figure 3. The results indicated that the absorption spectrum
of Hsp was similar to that of complex 1 with an intense
absorption band around 322nm. After the addition of ct-
DNA, the absorption bands of Hsp and complex 1 at 322
nm both exhibited obvious hypochromism about 30.3% for
Hsp, 39.4% for complex 1, although there was no obvious
red shift.
In order to investigate the interaction pattern of Hsp
and complex 1 with ct-DNA, ﬂuorescence emission titration
analyses were undertaken. The ﬂuorescence emission spectra
of Hsp and complex 1 in the absence and presence of calf
thymus DNA are shown in Figure 4. Hsp showed a weak
emission band around 284nm, and complex 1 exhibited a
strong emission band around 361nm. With the addition
of ct-DNA, the emission intensity of Hsp caused decrease,
whereas that of complex 1 displayed enhancement. The
emission intensity decrease of Hsp in the presence of DNA
maybecausedbythefactthatHspbeingasmallhydrophobic
molecule can be adsorbed by hydrophobic group on the
surface of DNA. Such a characteristic change is often
observed in DNA interactions [14]. The emission intensity
increase of complex 1 on addition of ct-DNA is ascribed
to a decrease of the collisional frequency of the solvent
molecules with the complex which caused by the planar
aromatic group of the complex stacks between adjacent
base pairs of ct-DNA [43]. Moreover, the emission intensity
of Hsp decreased signiﬁcantly reaching saturation with an
decreasing ratio of 7.26 at the [DNA]/[Hsp] ratio of 8 : 1,
whereas that of complex 1 enhanced reaching saturation
with an incremental ratio of 1.94 at the [DNA]/[Hsp] ratio
of 5 : 1. These variations may be caused by the fact that
the interaction degree was related to the planar area and
hydrophobic character, suggesting the binding aﬃnity of
complex 1 is stronger than that of free ligand.
Circular dichroism (CD) is a useful technique to assess
whether nucleic acids undergo conformational changes as a
result of complex formation or changes in the environment
[44]. The DNA helix has a right-hand chiral structure,6 Bioinorganic Chemistry and Applications
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Figure 4: Emission spectra of Hsp and 1 in the absence (----) and presence (—) of increasing amounts of DNA.
maintaining the B conformation in solution. The CD
absorption spectrum is very sensitive to conformational
changes in DNA; generally, in noncovalent binding states,
electrostatic and groove bindings show no signiﬁcant CD
spectral perturbation, because these two binding modes do
not inﬂuence the secondary structure of DNA. The observed
intensity change can be attributed to an intercalation mode
when small planar molecules interact with DNA.
As shown in Figure 5, the CD spectra of ct-DNA show
a positive band at 275nm and a negative band at 245nm,
due to base stacking and right-hand helicity, respectively,
consistent with the characteristic B conformation of DNA
[45, 46]. With addition of the compounds, the intensities
of the negative and positive bands decrease, but no red
shift is observed. These alterations in the CD spectrum of
DNA indicate strong conformational changes by Hsp and
complex 1. Also, Hsp and complex 1 bind DNA mainly by
intercalation mode.
Based on the UV-Vis spectral, ﬂuorescence and CD
measurements revealed that, with the addition of increasing
ct-DNA, complexes exhibited obviously hypochromism,
ﬂuorescence emission intensity enhancement, and CD spec-
trum change, which are important evidences of complex
interacting with the DNA by intercalation. In summary, Hsp
and complex 1bind DNA mainly by intercalation mode, and
the binding aﬃnity of complex 1 is stronger than that of free
ligand.
In addition, interactions of complexes 2 and 3 and
their ligands with calf thymus DNA were also investigated
under the same experiment condition. Similar results wereBioinorganic Chemistry and Applications 7
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obtained, and no obvious diﬀerences in the DNA binding
mode were founded.
4. Conclusion
Three ﬂavonoids copper(II) complexes were synthesized,
and their cytotoxic activities were estimated against HepG-
2, SGC-7901 and HeLa cell lines in vitro. The results
showed that complexes 1 and 3 showed higher inhibitory
rate than their free ligands against SGC-7901 and HepG2
cell lines; the inhibitory rate of complex 1 was 43.2% and
43.8%, while complex 3 was 46% and 36%, respectively. In
comparison with complex 2, complexes 1 and 3 exhibited
higher cytotoxicity towards selected cell lines, and complex
2 showed relatively signiﬁcant inhibitory rate only against
HepG2 cell lines than that of Nrg. The diﬀerence in
inhibition rates between the Cu(II) complexes of Apg and
Nrg was presumably due to the ﬂavone planar structure
of Apg. In contrast to the inhibitory activity of the Cu(II)
complexes with Nrg and Hsp, the high activity of Cu(II)
complex with Hsp may be related to the diﬀerent hydroxyl
(OH) substitutions in ring B. The binding properties with
calf thymus DNA revealed that Hsp and its Cu(II) complex
bind DNA mainly by intercalation mode. It conﬁrmed that
DNA is an important target in cellular systems for these
metal-based compounds derived from ﬂavonoids. The most
important contribution of this research is that the synergistic
enhancement eﬀects of ﬂavonoids with copper(II) ion may
be beneﬁt to further development as promising potential
metal-based anticancer drug.
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